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Objective—The purpose of this study was to examine: (a) the extent to which caregivers and
children asked asthma management questions during pediatric asthma visits, (b) the extent to
which providers engaged in shared decision-making with these caregivers and children, and (c) the
factors associated with question-asking and shared decision-making.
Methods—Children ages 8 through 16 with mild, moderate, or severe persistent asthma and their
caregivers were recruited at five pediatric practices in non-urban areas of North Carolina. All of
the medical visits were audio-tape recorded. Generalized estimating equations were used to
analyze the data.
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Results—Only 13% of children and 33% of caregivers asked one or more questions about
asthma management. Caregivers were most likely to ask questions about their child’s medications.
Providers obtained child input into their asthma management treatment plan during only 6% of
encounters and caregiver input into their child’s asthma management treatment plan during 10%
of visits.
Conclusion—Given the importance of involving patients during health care visits, providers
need to consider asking for and including child and caregiver input into asthma management
treatment plans so that shared decision-making can occur more frequently.
1. Introduction
Asthma is a worldwide problem and it is the most common chronic condition among
American children (1). There are more than 7 million children under age 18 in the United
States with asthma (2). Healthcare costs for asthma are estimated at more than 6 billion
dollars per year and the loss in productivity by working parents caring for children who miss
school due to asthma is estimated at one billion dollars per year (3–5).
The National Heart, Lung, and Blood Institute (NHLBI) guidelines provide several
recommendations for proper asthma management to minimize uncontrolled asthma. These
guidelines include: use of pharmacologic therapy, reduction in environmental triggers,
assess and monitor asthma control, and patient education (3). The patient education
guidelines specifically emphasize teaching patients how to effectively manage their asthma
as well as the importance of using a collaborative approach between providers, parents, and
children to develop an appropriate asthma management plan for the child. However, recent
studies have found that these guidelines are not being met, with less than half of families
ever receiving any education about their child’s asthma (6, 7). It is important to better
understand provider-child-caregiver communication about asthma during pediatric visits
because asthma patients who report poor communication with their providers have been
found to be less adherent with inhaled corticosteroids and have worse health outcomes than
patients who report good communication (8–10).
The U.S. Institute of Medicine report in 2001 endorsed patient-centered or family-centered
care and recommended that health care professionals implement the shared decision-making
model in clinical settings (11, 12). However, little empirical research, especially in pediatric
settings, has actually examined the extent to which shared decision-making is used in
practice with families. Charles et al. (13) argued that for shared decision-making to occur,
there needs to be a two-way exchange not only of information but also of treatment
preferences. Very few prior studies have examined the shared decision-making model with
families, and to our knowledge no prior work has examined the extent to which providers
ask for and include caregiver and child input into asthma management regimens during
primary care pediatric visits. Most prior studies that have examined provider-child-caregiver
communication during general pediatric visits have not examined the extent to which the
child and caregiver are sharing involvement in treatment decisions (14–18). Wassmer et al.
(19) examined communication during 51 pediatric visits and found that caregivers sought
information during 13% of visits and children asked for information during only 3% of
visits. The purpose of this study was to examine: (a) the extent to which caregivers and
children asked asthma management questions during pediatric asthma visits, (b) the extent to
which providers engaged in shared decision-making with these caregivers and children, and
(c) the factors associated with question-asking and shared decision-making.
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Participants—The cross-sectional study was approved by the University of North
Carolina Institutional Review Board. Providers were recruited at a convenience sample of
five pediatric practices in non-urban areas of North Carolina and provider consent was
obtained. Children and their caregivers of these providers who agreed to participate were
recruited. Children were eligible if they: (a) were ages 8 through 16 years, (b) were able to
speak English, (c) could read the assent form, (d) had been seen at the clinic at least once
before, (e) were present at the visit with an adult caregiver (parent or legal guardian) who
could read and speak English and who was at least 18 years of age, and (f) had mild,
moderate, or severe persistent asthma. Persistent asthma was defined as experiencing
asthma-related daytime symptoms more than twice a week, asthma-related nighttime
symptoms more than twice a month, or receiving one or more long-term control therapies
for asthma (4, 20).
Clinic staff referred potentially eligible and interested patients to a research assistant, who
explained the study; obtained caregiver consent and child assent, and administered the
eligibility screener (9). Providers and families were told that the study was examining
communication during pediatric visits. All of the medical visits were audio-tape recorded.
Children were interviewed after their medical visits. Caregivers completed self-administered
questionnaires. Data was collected between 2005 and 2008.
Audio-tape coding—All of the medical visit audio-tapes were transcribed verbatim, and a
detailed coding tool was developed to assess provider, child, and caregiver communication
about asthma. This tool was refined and tested over a one-year period. The categories used
in the coding tool for communication about asthma medications were adapted from the
categories used in prior studies of provider-patient communication about medications (21–
24) and the categories for child and caregiver input into the asthma management treatment
plan were created based on existing literature on shared decision-making and a thorough
review of the transcripts (11–13). The transcripts were reviewed by two research assistants
who met twice a month with the investigators to develop and refine the coding rules until
saturation of themes was achieved. The categories are described in detail below.
Using the coding tool for transcribed medical visits, coders recorded the following: (a) the
number and types of questions that children and caregivers asked about asthma medications,
asthma triggers and environmental trigger control, and monitoring devices such as peak flow
meters, (b) whether the provider asked for the child’s input into the asthma management
treatment plan, (c) whether the provider included the child’s input into the asthma
management treatment plan, (d) whether the provider asked for the caregiver’s input into the
asthma management treatment plan, and (e) whether the provider included the caregiver’s
input into the asthma management treatment plan.
Throughout the study period, two research assistants coded 20 of the same transcripts to
assess inter-coder reliability, which was calculated using inter-rater correlations. The inter-
rater correlation was 1.0 for the provider asking for caregiver input into the asthma
management treatment plan, 0.88 for the provider asking for child input into the asthma
management treatment plan, 1.0 for the provider including caregiver input into the asthma
management treatment plan, 0.88 for the provider including child input into the asthma
management treatment plan, 0.97 for number of caregiver questions about asthma
management, and 1.0 for whether the child asked one or more questions about asthma
management.
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Asthma health and medication characteristics—Medication use was assessed on the
caregiver eligibility screener, which asked about asthma symptoms and medication use.
When administering the eligibility screener, the research assistants showed caregivers a list
of asthma medications and asked them to indicate which one(s) the child was taking.
Responses were dichotomized based on whether the caregiver reported that the child was
taking a controller medication versus not taking a controller medication. Asthma severity
was classified as mild versus moderate/severe persistent by a research assistant based on
recent symptoms and medication use reported by the caregivers when research assistants
administered the eligibility screening instrument for the study (4, 5, 20). Our eligibility
screening instrument utilized the primary NHLBI asthma severity classification system that
was being used when the study was designed and conducted (4, 5, 20).
All child information was then reviewed by a pediatric pulmonologist or a clinical
pharmacist with expertise in asthma to verify the severity classification as mild or moderate/
severe persistent asthma and this classification was used in our analyses. The research
assistants and pediatric pulmonologist/clinical pharmacist agreed 99.4% of the time. Percent
agreement was calculated with the following formula: number of severity classifications that
were the same divided by the total number of classifications multiplied by 100. Severity was
classified using two different methods. The first method was medication use; any child
receiving a single long-term controller agent was considered to have mild persistent asthma.
Any child receiving two or more long-term controller agents was categorized as having
moderate-to-severe persistent asthma. The second method classified severity based on
symptom frequency. Caregivers were asked to think about their child’s symptoms over the
past 12 months. Subjects who reported the occurrence of any one of eight symptoms as
occurring two or more times per week or who reported awakening with asthma symptoms
two or more times per month was classified as mild persistent. The eight daytime symptoms
included: wheezing with a cold, wheezing without a cold, an episode of wheezing that made
it hard to breath or catch breath that lasted longer than a day or more, had a cough that
would not go away, complained that chest felt tight or heavy, used rescue inhaler for
symptoms, wheezed with exercise or running or playing hard, and coughed with exercise or
running or playing hard. The nighttime symptoms asked about how often the child’s sleep
had been disturbed because of wheezing, coughing, chest tightness, or shortness of breath.
Reports of daily symptom occurrence or awakening > 5 times a month resulted in a
classification as moderate or severe persistent. In situations where the two methods
(medication use and symptom frequency) resulted in discordant classification, the more
severe category was used.
Sociodemographic, cultural, and visit-related characteristics—A variety of
demographic, socio-cultural, and visit-related factors were examined as potential
confounders. Child and caregiver age, caregiver education, and years the child had asthma
were measured as continuous variables. Child and caregiver gender were also recorded. For
descriptive purposes, child race was re-coded into four categories: White, African American,
Native American/American Indian, or Other (includes categories of: Hispanic, Asian
American, other). However, for the bivariate analyses, child race was re-coded into a
dichotomous variable (White versus non-White). The child’s insurance status was assessed
using the following categories: none, private insurance, Medicaid, the State Children’s
Health Insurance Program (SCHIP), and other. How well the child thinks the provider
knows him/her as a person was measured with the following categories: hardly at all,
slightly, moderately well, and very well. Length of visit was measured in minutes. Whether
the child was currently taking a controller medication was measured as a dichotomous
variable. How long the caregiver and their family have known the doctor was measured with
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the following response categories: less than one year, between 1 and 2 years, between 3 and
4 years, and more than 4 years.
Statistical Analyses—All analyses were conducted using SPSS v. 14. First, we present
descriptive statistics for the child and caregiver demographic, socio-cultural, and visit
characteristics and the communication variables. Second, we examine bivariate relationships
between these variables using correlation coefficients, t-tests, or Pearson chi-square
statistics, as appropriate.
Next, we used generalized estimating equations (GEE) to examine how child, caregiver,
provider, and visit characteristics, as well as child and caregiver question-asking were
associated with: (a) whether the provider included child input into the asthma management
treatment plan and (b) whether the provider included caregiver input into the asthma




The five participating clinics were all primary care pediatric practices. Forty-one providers
agreed to participate in the study; two providers refused to participate for a participation rate
of 95.3%. Providers completed a short demographic questionnaire after providing consent.
Clinic staff referred eligible families to research assistants in the clinics. If families were
interested, they approached the research assistant. We do not know how many patients were
referred to the research assistants by the clinic staff because the clinic staff did not have time
to track this information.
Three hundred and thirty-three of the 377 families (88%) who approached the research
assistant to learn more about the study agreed to participate in the study. Two-hundred and
ninety six patients of the 333 participating patients (89%) had useable audio-tape data and
these patients were seen by 35 of the 41 providers who agreed to participate in the study.
Four of the 35 providers were nurse practitioners or physician assistants, and they saw
seventeen of the participating children. Fifty-one percent of the providers were female.
Twenty-seven of the providers were White, two were American Indian, three were African
American, one was Asian, and two classified their race as other. Providers ranged in age
from 30 to 70 years (mean = 44.8 years, standard deviation = 9.4).
Table 1 presents the child and caregiver demographic characteristics. Forty-six percent of
the children were female. The average age of the children was 11 years. Approximately 62%
of the children were White, 30% were African American, and 10% were Native American/
American Indian. In terms of the child’s asthma, caregivers reported that their children had
asthma for an average of six years. Seventy-two percent of these children had moderate-to-
severe persistent asthma. Only three families in the sample did not have health insurance.
Eighty-three percent of patients were on a controller medication.
Child question asking—Table 2 presents the extent to which children asked questions
about asthma management. Only 13% of children asked one or more questions about asthma
management. Children were most likely to ask about medications. Seven percent of children
asked clarifying questions and 4 percent asked about how to use asthma devices (e.g. multi-
dose inhalers). Only 2 children asked about peak flow meters and only 2 children asked
about environmental trigger control or asthma triggers. Table 3 presents the actual questions
that children asked about asthma management. Children were more likely to ask one or more
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questions about asthma medications during longer visits (t-test = 3.12, p ≤ 0.01); the average
length of visits where children asked one or more asthma management questions was 18.6
minutes (standard deviation = 7.0 minutes), whereas the average length of visits where
children did not ask one or more asthma management questions was 14.7 minutes (standard
deviation = 8.6 minutes).
Caregiver question asking—Table 2 also presents the extent to which caregivers asked
questions about asthma management. Thirty-three percent of caregivers asked one or more
questions about asthma management. Caregivers were most likely to ask medication
questions. Thirteen percent asked clarifying questions and 12% asked frequency of use or
timing questions. Only 5% of caregivers asked environmental trigger control or asthma
trigger questions and 3% asked peak flow meter questions. Table 4 presents examples of the
types of questions that caregivers asked about asthma management.
Caregivers were significantly more likely to ask any questions about asthma management if
their child was on one or more controller medications (Pearson chi-square = 4.04, p ≤ 0.05).
Thirty-five percent of caregivers whose children were on controller medications asked one
or more questions compared to 19% of caregivers whose children were not on controller
medications. Caregivers were also significantly more likely to ask any questions about
asthma management during longer visits (t-test = 3.05, p ≤ 0.01); the average length of visits
where caregivers asked one or more asthma management questions was 17.3 minutes
(standard deviation = 7.9 minutes), whereas the average length of visits where caregivers did
not ask asthma management questions was 14.2 minutes (standard deviation = 8.6 minutes).
Caregivers were significantly more likely to ask one or more asthma medication questions if
they were present with younger children (t-test = 3.5, p ≤ 0.01).
Providers asking for and including child and caregiver input into the asthma
management treatment plan—Providers asked for child input into the asthma
management treatment plan during only 7% of encounters. Providers included child input
into the asthma management regimen during only 6% of encounters (n = 19). During 18 of
these 19 visits, the provider asked for the child’s input and included it, but during only one
visit was the child’s input included when the provider had not asked for it. Below is an
excerpt from a visit where the provider asked for the child’s input and included it in the
asthma management treatment plan:
Provider: The Advair now comes in an inhaler, and the one that you are used to, the purple disk? Which one do you
prefer? Using an inhaler or the round disk?
Patient: The inhaler.
Provider: The inhaler? You felt much better? Okay. It is still the same medication it is just in a different form? It
doesn’t have that powdery taste.
Patient: Alright.
Provider: So, um, we can talk about switching your medication to an inhaler form, okay? But again it comes in
different strengths. It also has the same three strengths, the 100/50, the 250/50, and the 500/50, do you
remember which one it was? Did it come in the green, yellow, or red?
Patient: I’d say green.
Provider: Green? Cause that is the lowest. Green is the 100/50, the yellow is the 250/50, and the red is the 500/50,
okay? So, it is like the stop sign: green is good, yellow is caution, red is bad, okay? So, you need to take
your medicine every single day okay? Otherwise you will be back here, and you will say I don’t feel good.
Your Advair, you have got to take it every single day whether you are well or not, okay? So it just depends
on you not feeling good and that needs to you need to carry yourself to the doctor because sometimes we
need to bump up your dose of the Advair, like right now I am leaning on putting you on the middle strength
of the Advair, okay? Because you have had symptoms for the last three months and then we start backing
up. That’s why it’s important you come back, okay?
Patient: Okay.
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Provider: In about three weeks, let’s see if we need to bump him up more, or we can go down to the green but right
now we are going to go with the yellow, okay? Advair, got it?
Patient: Yep.
Provider: And you need to use it properly, first time you use a canister of albuterol, or the Advair, whichever you
have, you have to shake it good and prime it. Prime it is when you waste a few squirts ok? And then you
use it, next time you use it you don’t have to prime it. Ok?
Patient: Okay.
Provider: Do you have any questions for me?
Patient: No.
Provider: No? Okay.
In the above excerpt, the provider asked for the child’s input, but the provider does it in a
more close-ended way and the child chooses the dosage form that he prefers.
Table 5 presents the GEE results examining whether providers included child input into the
asthma management treatment plan. Providers were significantly more likely to include
child input into the asthma management treatment plan when the children were at visits with
male caregivers (p ≤ 0.01). Providers asked for child input during 21% of visits when
children were present with male caregivers, whereas they only asked for child input during
5.1% of visits when children were present with female caregivers. Including child input into
the asthma management treatment plan was not significantly associated with any of the other
child, caregiver, or provider characteristics or length of visit.
Providers asked for caregiver input into the asthma management regimen during 10% of
visits (N=29). Providers included caregiver input into the asthma management regimen
during 10% of visits (N = 29). During 25 of the visits, the provider asked for the caregiver’s
input and included it, but during only four visits was the caregiver’s input included when the
provider had not asked for it. Below is an example of caregiver input into the asthma
management regimen:
Caregiver: (Unclear) doing so good and I thought yeah, we’ve been taking this medicine since he was six months old
he has been taking this medicine.
Provider: Okay.
Caregiver: And I’m, I’m just I’m tired however I know that he has to have it because I, I, we’ve missed it one night.
__ walked in the house he said __ get him up out of bed and give him his medicine. I know there’s no way
you could have given his medicine because I can hear him.
Provider: Snoring?
Caregiver: Yeah, he could just hear him breathing. He wasn’t really snoring. It was, I mean I don’t know how it was
just (unclear).
Caregiver: So he I gave him, I got him up and gave him his medicine. Um, about…
Child: About four or five o’clock in the morning.
Caregiver: well you know it wasn’t that late. About a week after that he just, he fell asleep before I gave him his
medicine and um, and it was the same thing. He just was tossing and turning and he just couldn’t sleep.
His breathing was just labored.
Provider: Now and we’re just on singulair and zyrtec, right?
Caregiver: Yeah.
Provider: That’s not terrible.
Caregiver: I know but…
Provider: Those have really got a great safety profile.
Caregiver: I understand but I you know I, I was just saying that I was tired of, of us doing it
Provider: Summertime next year we’ll try him off then.
Caregiver: Okay.
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In the above encounter, the caregiver is admitting that she is tired of the current medication
regimen but the provider cuts off the caregiver and says they will try to get the child off of
the medication next summer. By ignoring this request, non-adherence may continue which
could be causing the increased need for albuterol. It is important for providers to listen and
respond to concerns so that medication regimens that fit the family’s lifestyle better can be
put into place.
Table 6 presents the GEE results predicting whether providers included caregiver input into
the asthma management treatment plan. Younger providers were significantly more likely to
include caregiver input into the asthma management treatment plan than older providers (p ≤
0.05). Providers were significantly more likely to include caregiver input into the asthma
management regimen if caregivers asked more asthma management questions during the
visit (p ≤ 0.05).
4. Discussion
Providers asked for child input into the asthma management treatment plan during less than
10% of visits which is contrary to the current clinical practice guidelines of the National
Asthma Education and Prevention Program of the National Heart Lung and Blood Institute
which encourages providers to jointly determine the goals of treatment with the patient and
family (3, 4). Shared decision-making is not occurring to a large extent with children with
asthma, because for shared decision-making to occur there needs to be a two-way exchange
not only of information but also of treatment preferences (13). Providers need to consider
asking and including child input into their treatment plans because including child input
could possibly improve adherence and health outcomes (19, 25).
Encouraging child involvement may enhance the child’s self-confidence and improve their
management skills (26–28). Information received from a child may provide information that
differs from the caregiver’s report and may actually improve the child’s care (15, 29). Future
research needs to design and test interventions that can be used to facilitate child
involvement during pediatric asthma visits.
Providers did not include caregiver input into the asthma management treatment plan much
more than they included child input. This indicates that shared decision-making with
caregivers is also not occurring very often. If caregivers asked more questions about asthma
management during the visits, providers were more significantly more likely to include
caregiver input into the asthma management regimen. Only one-third of caregivers asked
questions about asthma management during these pediatric visits. Caregivers should be
encouraged to ask questions about asthma management because it could lead to more shared
decision-making occurring during pediatric asthma visits. Innovative methods to encourage
caregiver question-asking could be developed and tested.
Younger providers were significantly more likely to include caregiver input into the asthma
management treatment plan than older providers. Our finding is similar to that of Young et
al. (30) who found that younger physicians used shared decision-making more than older
physicians during depression care visits. Future research should examine how providers of
all ages can be taught and encouraged to include caregiver and child input into asthma
management regimens. Wales, Elwyn and colleagues conducted a randomized trial that
educated physicians about risk communication and shared decision-making (31, 32).
Physicians attended four workshops that were three hours each (two workshops were on risk
communication and two were on shared decision-making). Shared decision-making
improved after providers attended the workshops. Other countries could attempt to design
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programs similar to the ones Elwyn et al. (31) used in Wales to see if the shared decision-
making skills of providers can be improved.
Less than 5 percent of caregivers and less than 1 percent of children asked questions about
asthma triggers or environmental trigger control. Providers should educate caregivers about
what types of things might trigger their child’s asthma symptoms, such as pollens, indoor
mold, cigarette smoke, animal dander, cockroaches, dust mites, and other irritants. Once
caregivers have been educated about common asthma triggers, they may be better positioned
to identify methods for eliminating triggers or ask their providers for suggestions on how to
eliminate them. Simple communication-focused interventions that encourage caregivers or
children to ask “What types of things or activities might trigger asthma symptoms?” and
“How could I avoid these triggers?” may help encourage trigger-related discussions during
asthma visits. Our work found that environmental control strategies were discussed in less
than 27% of visits (33), which further reinforces that this is an area of communication that
needs improvement.
Children were significantly more likely to ask questions during longer visits. The mean visit
length was approximately 4 minutes longer if children asked questions about their asthma
management. Future research should examine whether child self-management skills and
their asthma outcomes are improved if they ask questions during medical visits so that we
can examine whether increased visit lengths might be cost effective.
The study is limited in generalizability in that it was conducted in five pediatric clinics in
non-urban areas of North Carolina. Another limitation is that clinic staff referred potentially
eligible patients to the research assistant, and we do not know how many patients that the
clinic staff referred chose not to talk with the research assistant. However, we could not ask
the clinic staff to track these numbers because of how busy the clinics were and our promise
not to interrupt clinic flow. Another limitation is that we measured basic child demographics
and we did not include intelligence or personality measures which could impact provider-
patient communication. Another limitation is that we chose audio-taping rather than video-
taping the medical visits because it is less intrusive and fewer individuals mind being audio-
taped as opposed to being video-taped. Our multivariable GEE analyses might have yielded
few significant findings because of the skewed nature of the outcome variables (child and
caregiver input was not included into asthma management regimens very often). Despite the
limitations of the study, it presents new information on child and caregiver question-asking
about asthma management and the extent to shared decision-making occurs with children
and caregivers during pediatric asthma visits.
Conclusions
Only 13% of children asked questions about asthma management and the majority of
questions they asked were about medications. The U.S. Pharmacopoeia (USP) supports the
rights of children and adolescents to receive developmentally appropriate medication
information (34). Two of their guiding principles are: (a) children want to know about
medicines-health care providers and health educators should communicate directly with
children about medicines and (b) children’s interest should be encouraged, and they should
be taught how to ask health care providers questions about medicines (33). Future research
should develop and test ways to find out what types of questions children have about their
asthma and how to motivate children to ask more questions about their asthma management.
Providers obtained child input into their asthma management treatment plan during only 6%
of encounters and caregiver input into their child’s asthma management treatment plan
during 10% of visits. Providers need to consider asking for and including child and caregiver
input into asthma management treatment plans so that shared decision-making can occur
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more frequently. Future work should develop and test interventions that train providers on
how to ask for and include child and caregiver input more when asthma management
treatment plans are being put together.
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Table 1
Child and Caregiver Demographic Characteristics (N = 296)
Percent (N)
Child Age
 Mean (SD) Range 11.1 (2.4) 8–16 years
Child Gender
 Male 53.7 (159)
 Female 46.3 (137)
Child Race
 White 61.5 (182)
 African American 30.1 (89)
 Native American/American Indian 10.1 (30)
 Other 6.1 (18)
Asthma Severity
 Mild persistent 28.0 (83)
 Moderate/Severe persistent 72.0 (213)
Number of years living with asthma
 Mean (SD) Range 6.0 (3.9) 9–16 years
Caregiver relationship status
 Never 16.2 (48)
 Married 57.8 (171)
 Separated 9.5 (28)
 Divorced 12.5 (37)
 Widowed 3.0 (9)
Caregiver Age
 Mean (SD) Range 42.0 (8.4) 27–81 years
Caregiver Gender
 Male 14.2 (42)
 Female 85.8 (253)
Caregiver Education in Years
 Mean (SD) Range 12.8 (2.5) 2–20 years
Insurance Type
 None 1.0 (3)
 Private 26.4 (78)
 Medicaid 51.7 (153)
 State Children’s Health Insurance Program 17.6 (52)
 Other 2.7 (8)
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Table 2
The frequency and types of questions asked about asthma by children and caregivers (N=296)
Types of Questions Asked Subcategory Children Percent (N) Caregivers Percent (N)
Medications
Asks for clarification or checks for
understanding
7.1 (21) 13.2 (39)
Barriers or Side effects 0.7 (2) 3.7 (11)
Device/Technique 3.7 (11) 4.7 (14)
Dosage 0 (0) 2.0 (6)
Duration 0.7 (2) 3.0 (9)
Frequency/Timing 3.0 (9) 11.5 (34)
Purpose 0.3 (1) 3.0 (9)
Quantity/Supply 1.0 (3) 6.4 (19)
School use 0.7 (2) 2.4 (7)
Type of medicine 0 (0) 2.4 (7)
Other 1.0 (3) 3.4 (10)
Peak Flow Meter 0.7 (2) 3.0 (9)
Environmental Trigger Control or
Asthma Triggers
0.7 (2) 4.8 (14)
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Table 3
Actual questions asked by the children
Types of Questions Asked Subcategory Actual Question
Medication
Asks for clarification or checks for
understanding
Which one is that?
It is, ain’t it?
That’s the maxair stuff?
Oh, it is?
What’s that one?
The one I ((sounds of inhaling))? … the purple thing, advair,
what you call it?
The inhaler?
Them little white pills?
The purple thing advair what you call it?
So is that the advair?
The q-var?
So what do I get?
Is that like with the (unclear)?
My inhaler?
What is that?
What is that again?
What’s that?
And then that’s (unclear) for hours?
I need an inhaler?
Was I supposed to use the um, pulmicort once a day?
So that’s eight puffs a day?
Barriers or Side Effects
Is it going to taste better?
It won’t hurt me will it?
Device/Technique
What’s a spacer?
Mom is the spacer that green thing?
How many times do I click it?
You can tilt it?
Was I supposed to take that um, stuff for my nose?
What’s a disc?
When you say two puffs do I close it again and do it?
Okay, how long should I hold it?
Is that a right?




Oh, so I still use both?
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Types of Questions Asked Subcategory Actual Question
Frequency/Timing
As many times a day?
If I go swimming or something like that will I still take the
albuterol?
Ok so before we get active go ahead and do it?





How many times do I take that?
I do it when I don’t need it?
Purpose Is it, was it like the albuterol?
Quantity/Supply
Will I get it today?
Does that have medicine in it?
Will I get to keep the inhaler?
School Use
Can I get one of those pump things for school?
Do you think I should take it to PE?
Other
What’s a pulmicort?
Can I (unclear) if I take the medicine?
Can I throw the pulmicort in the trash can?
Peak Flow Meter
So my green is like two seventy?
What happens when it’s red?




How about exercise at my daycare?
Just like me jumping on the trampoline?
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Table 4
Actual questions asked by the caregivers
Types of Questions
Asked Subcategory Actual Question
Medication
Asks for clarification or
checks for understanding
So, it is that one you turn at the bottom?
Do you think that would be something appropriate to do?
So actually he don’t need the machine anymore just the spacer?
Does she need both of those together?
Is it the advair or the inhaler, I forgot?
Advair is the purple thing, what’s the other?
Which one is she supposed to be on?
When he finishes that do another puff and do the same thing?
Barriers or Side Effects
What are the side effects of singulair?
There is not any kind of danger in that advair is there?
Are you going to keep her on this … it made her sick and throw up?
And it’s safe together?
Device/Technique
The thing like what you just used?
But you don’t turn like the advair every time?
Okay, so when he is wheezing that is when he uses [the inhaler with the
spacer]?
You were talking about doing a nebulizer treatment when you say twenty
minutes or does it matter which?
Dosage
The dose he is taking is still okay?
Is it the same one, but it’s the higher dose?
Umm, does he need to go up on that or is that still okay?
Duration
Okay, he’s not going off the singulair?
Yeah, now how long does he need that?
Frequency/Timing
The steroid inhaler would he do it every day?
What time do I give him the prednisone in the morning or at night?
But you do want him before he goes outside to play to use?
The advair that she takes is everyday two times a day, right?
Is that one the same like in the morning or just as needed?
Purpose
Should that help her too with like exercising and stuff like that?
For like a rescue?
Would you expect that with his advair using it twice a day the way you had
recommended that at some point he would be able to run as hard as he wanted
to?
Is that why it didn’t work at all on Sunday then?
Quantity/Supply
Does he need two prescriptions one for school and one for home?
How will I know the advair gets low?
So I would need probably two air chambers then?
It does, how much it have in it?
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Types of Questions
Asked Subcategory Actual Question
So there’s enough in there for three months?
Will you write me a new prescription for singulair?
How often is she supposed to get a new machine?
School use
Do you think he would need um, some medicine at school?
So there will be two?
Will she have one for home and one to keep at school?
Type of medicine
All those are rescue type medicine?
But it’s not albuterol?
What is serevent another antibio, I mean um, um, steroid?
So Advair is an inhaled corticosteroid right?
Other
Can you give him a pill if you give him that?
Because doesn’t singulair contain an antihistamine?
If he needs his inhaler he can still use that?
Okay, it seems like the pills he takes now is chewable, the 10’s are not
chewable?
Okay, so that is something you do daily?
Peak Flow Meter
Yeah, I just wasn’t sure what it was supposed to go up to for him.
How many do you want me to record?
Okay, now how often does he do that little thing?




I know something else I was going to ask you, he cuts grass, is it good for him
to cut grass?
How would playing the clarinet, flute, or drums affect her asthma?
Do you think this season is going to be worse with the drought on allergies,
ragweed, and stuff?
Do you think that mold in our house, we have an old house?
Do you think the cat would be a factor that we should eliminate?
So, she shouldn’t be around him smoking and stuff, that’s bad on her asthma?
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Table 5
Generalized estimating equation results predicting whether provider includes child input into the asthma
management regimen (N=296)
Independent Variables Odds Ratio (95% Confidence Interval)
Child’s severity of asthma- moderate severe 0.85 (0.23, 3.10)
Years living with asthma 1.03 (0.90, 1.19)
Taking a controller medication 0.97 (0.30, 3.20)
Child age in years 1.15 (0.86, 1.53)
Child gender- female 0.84 (0.20, 3.46)
Child race- White 2.34 (0.86, 6.37)
How well child feels provider knows them as a person 0.77 (0.36, 1.66)
Caregiver gender- female 0.19 (0.06, 0.57)**
Caregiver years of education 1.01 (0.87, 1.18)
Provider gender- female 0.65 (0.15, 2.77)
Provider race- White 0.26 (0.06, 1.13)
Provider age 0.95 (0.88, 1.03)
Length of visit 1.00 (1.00, 1.00)
Did the child ask any asthma management questions 1.11 (0.18, 6.94)
Number of caregiver asthma management questions 1.20 (0.85, 1.71)
**
p < 0.01
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Table 6
Generalized estimating equation results predicting whether the provider includes caregiver input into the
asthma management regimen (N=296)
Independent Variables Odds Ratio (95% Confidence Interval)
Child’s severity of asthma- moderate severe 0.63 (0.22, 1.80)
Years living with asthma 1.01 (0.98, 1.03)
Taking a controller medication 1.41 (0.34, 5.82)
Child age in years 0.87 (0.70, 1.09)
Caregiver age 1.00 (0.94, 1.06)
Caregiver gender- female 4.11 (0.50, 34.04)
Caregiver race- White 0.52 (0.19, 1.47)
Caregiver years of education 1.07 (0.88, 1.30)
How long you and your family have known the doctor 1.79 (1.00, 3.22)
Provider gender- female 1.02 (0.32, 3.28)
Provider race- White 0.43 (0.10, 1.79)
Provider age 0.93 (0.87, 0.99)*
Length of visit 1.00 (1.00, 1.00)
Did the child ask any asthma management questions 1.84 (0.51, 6.67)
Number of caregiver asthma management questions 1.39 (1.06, 1.81)*
*
p< 0.05
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